Mechanism and significance of cell type-dependent neutralization of flaviviruses

• Published in: Journal of virology 2014-07, Vol.88 (13), p.7210-7220
• Main Authors: Mukherjee, Swati, Dowd, Kimberly A, Manhart, Carolyn J, Ledgerwood, Julie E, Durbin, Anna P, Whitehead, Stephen S, Pierson, Theodore C
• Format: Article
• Language: English
• Subjects: Animals; Antibodies, Monoclonal - immunology; Antibodies, Neutralizing - immunology; Antibodies, Viral - immunology; Cells, Cultured; Cercopithecus aethiops; Clinical Trials, Phase I as Topic; Cricetinae; Cross Reactions; Dengue - immunology; Dengue - virology; Dengue virus; Dengue Virus - immunology; Epitopes - immunology; Flavivirus; Flavivirus - immunology; HEK293 Cells; Humans; Neutralization Tests; Vaccines and Antiviral Agents; Vero Cells; Viral Vaccines - immunology; Virion - immunology; Volunteers
• ISSN: 0022-538X; 1098-5514
• DOI: 10.1128/JVI.03690-13

The production of neutralizing antibodies (NAbs) is a correlate of protection for many human vaccines, including currently licensed vaccines against flaviviruses. NAbs are typically measured using a plaque reduction neutralization test (PRNT). Despite its extensive use, parameters that impact the performance of the PRNT have not been investigated from a mechanistic perspective. The results of a recent phase IIb clinical trial of a tetravalent dengue virus (DENV) vaccine suggest that NAbs, as measured using a PRNT performed with Vero cells, do not correlate with protection. This surprising finding highlights the importance of understanding how well the PRNT captures the complexity of the NAb response to DENV. In this study, we demonstrated that the structural heterogeneity of flaviviruses arising from inefficient virion maturation impacts the results of neutralization assays in a cell type-dependent manner. Neutralization titers of several monoclonal antibodies were significantly reduced when assayed on Vero cells compared to Raji cells expressing DC-SIGNR. This pattern can be explained by differences in the efficiency with which partially mature flaviviruses attach to each cell type, rather than a differential capacity of antibody to block infection. Vero cells are poorly permissive to the fraction of virions that are most sensitive to neutralization. Analysis of sera from recipients of live-attenuated monovalent DENV vaccine candidates revealed a strong correlation between the sensitivity of serum antibodies to the maturation state of DENV and cell type-dependent patterns of neutralization. Cross-reactive patterns of neutralization may be underrepresented by the "gold-standard" PRNT that employs Vero cells. Cell type-dependent patterns of neutralization describe a differential capacity of antibodies to inhibit virus infection when assayed on multiple cellular substrates. In this study, we established a link between antibodies that neutralize infection in a cell type-dependent fashion and those sensitive to the maturation state of the flavivirus virion. We demonstrated that cell type-dependent neutralization reflects a differential capacity to measure neutralization of viruses that are incompletely mature. Partially mature virions that most efficiently bind maturation state-sensitive antibodies are poorly represented by assays typically used in support of flavivirus vaccine development. The selection of cellular substrate for neutralization assays may sign